Global Albumin Excipient Market Report 2024

Albumin Excipient Global Market Report 2025 – By Product (Human Serum Albumin, Recombinant Albumin), By End-Users (Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Albumin Excipient Global Market Report 2025

Report Price : $4490.00 | Pages : | Published : January 2025 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Albumin Excipient Global Market Report 2025

Proud Members Of

checkslacipN checkaoirsN checkscipN

Albumin Excipient Market Definition

Albumin excipient is a type of protein that is found in blood. An excipient is an inactive ingredient that serves as a carrier or stabilizer for the active pharmaceutical ingredient.

The main product types of albumin excipients are human serum albumin and recombinant albumin. Human Serum albumin is the primary protein made by the liver and is present in the human plasma. These are used by various end-users such as the pharmaceutical and biotechnology industry, research institutes, and others.

Albumin Excipient Market Segmentation

The albumin excipient market covered in this report is segmented –

1) By Product: Human Serum Albumin, Recombinant Albumin

2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users

Subsegments:

1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin

2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin

Albumin Excipient Market Size and growth rate 2025 to 2029: Graph

Albumin Excipient Market Size 2025 And Growth Rate

The albumin excipient market size has grown strongly in recent years. It will grow from$4.85 billion in 2024 to $5.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to biopharmaceutical industry growth, increased adoption of biologics, risen prevalence of chronic diseases, clinical advancements and drug innovation, increased focus on drug delivery

Albumin Excipient Market Growth Forecast

The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to continued biopharmaceutical expansion, growing biologics pipeline, rising geriatric population, global vaccination initiatives, increasing drug development investments. Major trends in the forecast period include biodegradable and biocompatible properties, collaborations and partnerships in research, regulatory compliance and quality standards, application in cell therapy, customization and tailored solutions.

Albumin Excipient Market Driver: Chronic Disease Rise Fuels Albumin Excipient Market Growth

The rising prevalence of chronic diseases is expected to propel the growth of the albumin excipient market going forward. A chronic disease is a form of illness that lasts three months or more and can deteriorate with time. Albumin is used as a blood volumizer and is the most abundant circulating protein in plasma that acts as a versatile protein carrier for drug targeting and for improving the pharmacokinetic profile of peptide or protein-based drugs is involved in the treatment of various diseases, including cancer, and diabetes. For instance, in February 2024, according to the World Health Organization, a Switzerland-based agency of the United Nations, It is projected that over 35 million new cancer cases will arise by 2050, marking a 77% increase compared to the estimated 20 million cases in 2022. Therefore, the rising prevalence of chronic diseases is driving the growth of the albumin excipient market.

Albumin Excipient Market Driver: Increasing Healthcare Expenditures Boosting The Albumin Excipient Market Growth

The rise in healthcare expenditures is expected to propel the growth of the albumin excipient market going forward. Health expenditures refer to all costs associated with providing health services, family planning activities, nutrition programs, and emergency help with a focus on health. Increasing healthcare expenditure positively influences the albumin excipient market by providing greater financial support for the development and utilization of advanced albumin-based formulations in pharmaceuticals and biopharmaceuticals. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health expenditure is projected to reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Therefore, the rise in healthcare expenditures is driving the growth of the albumin excipient market.

Global Albumin Excipient Market Major Players

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.

Global Albumin Excipient Market Trend: Innovative Strategic Partnership Propel Market Growth

Major companies operating in the albumin excipient market are adopting a strategic partnership approach to provide essential biotechnology and pharmaceutical sectors. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in October 2023, ARTES Biotechnology GmbH is Germany-based biotechnology company partnered with Basic Pharma is a Netherlands-based, pharmaceutical company to advance recombinant protein production. With this partnership, they aim to advance pharmaceutical recombinant protein production by streamlining the supply chain and reducing time-to-market for new products.

Global Albumin Excipient Market Trend: Strategic Collaborations Fuel Advancements In The Albumin Excipient Market

Major companies operating in the albumin excipient market are forming collaborations to develop a new relationship in which two or more organizations develop new medicines. In June 2023, Albumedix Ltd., a UK-based pharmaceutical company, expanded its collaboration with Valneva SE to include Valneva's newly approved inactivated COVID-19 vaccine, VLA2001. The collaboration aims to address significant unmet medical needs, and the inclusion of Albumedix's rHA in the vaccine is seen as a significant contribution to its manufacture. VLA2001 is the only whole virus, inactivated, adjuvanted vaccine candidate in clinical trials against COVID-19 in Europe and is intended for the active immunization of at-risk populations to prevent carriage and symptomatic infection. Valneva SE is a France-based biotech company specializing in the development, manufacturing, and commercialization of prophylactic vaccines for infectious diseases.

Albumin Excipient Market Merger And Acquisition: Sartorius Strengthens Bioprocess Solutions With Albumedix Acquisition

In September 2022, Sartorius AG, a Germany-based pharmaceutical and laboratory equipment manufacturer, acquired Albumedix for a deal amount of $503 million. With this acquisition, Sartorius Inc. would strengthen its cell culture media business by expanding its portfolio of bioprocess solutions. Albumedix is a UK-based company that develops and manufactures recombinant human albumin products.

Regional Analysis For The Global Albumin Excipient Market

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the albumin excipient market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Albumin Excipient Market?

The albumin excipient market consists of sales of ovalbumin, and bovine serum albumin. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Albumin Excipient Industry?

The albumin excipient market research report is one of a series of new reports from The Business Research Company that provides albumin excipient market statistics, including albumin excipient industry global market size, regional shares, competitors with an albumin excipient market share, detailed albumin excipient market segments, market trends and opportunities, and any further data you may need to thrive in the albumin excipient industry. This albumin excipient market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Albumin Excipient Market Report Forecast Analysis
Report AttributeDetails
Market Size Value In 2025 $5.2 billion
Revenue Forecast In 2034 $6.77 billion
Growth Rate CAGR of 6.8% from 2024 to 2033
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users Subsegments: 1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Albumin Excipient Market Characteristics

    3. Albumin Excipient Market Trends And Strategies

    4. Albumin Excipient Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

    5. Global Albumin Excipient Growth Analysis And Strategic Analysis Framework

    5.1. Global Albumin Excipient PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

    5.2. Analysis Of End Use Industries

    5.3. Global Albumin Excipient Market Growth Rate Analysis

    5.4. Global Albumin Excipient Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

    5.5. Global Albumin Excipient Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

    5.6. Global Albumin Excipient Total Addressable Market (TAM)

    6. Albumin Excipient Market Segmentation

    6.1. Global Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Human Serum Albumin

    Recombinant Albumin

    6.2. Global Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Pharmaceutical And Biotechnology Industry

    Research Institutes

    Other End Users

    6.3. Global Albumin Excipient Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    5% Human Serum Albumin

    20% Human Serum Albumin

    6.4. Global Albumin Excipient Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    Recombinant Human Serum Albumin

    Recombinant Bovine Serum Albumin

    7. Albumin Excipient Market Regional And Country Analysis

    7.1. Global Albumin Excipient Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    7.2. Global Albumin Excipient Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8. Asia-Pacific Albumin Excipient Market

    8.1. Asia-Pacific Albumin Excipient Market Overview

    Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    8.3. Asia-Pacific Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    9. China Albumin Excipient Market

    9.1. China Albumin Excipient Market Overview

    9.2. China Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    9.3. China Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

    10. India Albumin Excipient Market

    10.1. India Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    10.2. India Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11. Japan Albumin Excipient Market

    11.1. Japan Albumin Excipient Market Overview

    11.2. Japan Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    11.3. Japan Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12. Australia Albumin Excipient Market

    12.1. Australia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    12.2. Australia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13. Indonesia Albumin Excipient Market

    13.1. Indonesia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    13.2. Indonesia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14. South Korea Albumin Excipient Market

    14.1. South Korea Albumin Excipient Market Overview

    14.2. South Korea Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    14.3. South Korea Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15. Western Europe Albumin Excipient Market

    15.1. Western Europe Albumin Excipient Market Overview

    15.2. Western Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    15.3. Western Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16. UK Albumin Excipient Market

    16.1. UK Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    16.2. UK Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17. Germany Albumin Excipient Market

    17.1. Germany Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    17.2. Germany Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18. France Albumin Excipient Market

    18.1. France Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    18.2. France Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19. Italy Albumin Excipient Market

    19.1. Italy Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    19.2. Italy Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20. Spain Albumin Excipient Market

    20.1. Spain Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    20.2. Spain Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21. Eastern Europe Albumin Excipient Market

    21.1. Eastern Europe Albumin Excipient Market Overview

    21.2. Eastern Europe Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    21.3. Eastern Europe Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22. Russia Albumin Excipient Market

    22.1. Russia Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    22.2. Russia Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23. North America Albumin Excipient Market

    23.1. North America Albumin Excipient Market Overview

    23.2. North America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    23.3. North America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24. USA Albumin Excipient Market

    24.1. USA Albumin Excipient Market Overview

    24.2. USA Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    24.3. USA Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25. Canada Albumin Excipient Market

    25.1. Canada Albumin Excipient Market Overview

    25.2. Canada Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    25.3. Canada Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26. South America Albumin Excipient Market

    26.1. South America Albumin Excipient Market Overview

    26.2. South America Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    26.3. South America Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27. Brazil Albumin Excipient Market

    27.1. Brazil Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    27.2. Brazil Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28. Middle East Albumin Excipient Market

    28.1. Middle East Albumin Excipient Market Overview

    28.2. Middle East Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    28.3. Middle East Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29. Africa Albumin Excipient Market

    29.1. Africa Albumin Excipient Market Overview

    29.2. Africa Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    29.3. Africa Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

    30. Albumin Excipient Market Competitive Landscape And Company Profiles

    30.1. Albumin Excipient Market Competitive Landscape

    30.2. Albumin Excipient Market Company Profiles

    30.2.1. Albumin Therapeutics LLC Overview, Products and Services, Strategy and Financial Analysis

    30.2.2. Biotest AG Overview, Products and Services, Strategy and Financial Analysis

    30.2.3. CSL Behring Overview, Products and Services, Strategy and Financial Analysis

    30.2.4. Grifols S.A. Overview, Products and Services, Strategy and Financial Analysis

    30.2.5. HiMedia Laboratories LLC Overview, Products and Services, Strategy and Financial Analysis

    31. Albumin Excipient Market Other Major And Innovative Companies

    31.1. InVitria Inc.

    31.2. Medxbio Pte Ltd.

    31.3. Octapharma AG

    31.4. RayBiotech Inc.

    31.5. SeraCare Life Sciences Inc.

    31.6. Sigma-Aldrich Pty. Ltd.

    31.7. Hualan Biological Engineering Inc.

    31.8. Kedrion Biopharma

    31.9. LFB USA Inc.

    31.10. Shanghai RAAS Blood Products Co. Ltd.

    31.11. Baxter International Inc.

    31.12. Merck KGaA

    31.13. Thermo Fisher Scientific Inc.

    31.14. Albumedix A/S

    31.15. Bio Products Laboratory Ltd.

    32. Global Albumin Excipient Market Competitive Benchmarking And Dashboard

    33. Key Mergers And Acquisitions In The Albumin Excipient Market

    34. Recent Developments In The Albumin Excipient Market

    35. Albumin Excipient Market High Potential Countries, Segments and Strategies

    35.1 Albumin Excipient Market In 2029 - Countries Offering Most New Opportunities

    35.2 Albumin Excipient Market In 2029 - Segments Offering Most New Opportunities

    35.3 Albumin Excipient Market In 2029 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Albumin Excipient Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Albumin Excipient Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Albumin Excipient Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Albumin Excipient Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: China, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: India, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: India, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Japan, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Japan, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Australia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Australia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Indonesia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Indonesia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: South Korea, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: South Korea, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Western Europe, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Western Europe, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: UK, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: UK, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Germany, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Germany, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: France, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: France, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Italy, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Italy, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Spain, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Spain, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Eastern Europe, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Eastern Europe, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Russia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Russia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: North America, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: North America, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: USA, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: USA, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Canada, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Canada, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: South America, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: South America, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Brazil, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Brazil, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Middle East, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Middle East, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Africa, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Africa, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Albumin Therapeutics LLC Financial Performance
  • Table 54: Biotest AG Financial Performance
  • Table 55: CSL Behring Financial Performance
  • Table 56: Grifols S.A. Financial Performance
  • Table 57: HiMedia Laboratories LLC Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Albumin Excipient Market, Sub-Segmentation Of Human Serum Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Albumin Excipient Market, Sub-Segmentation Of Recombinant Albumin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Albumin Excipient Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Albumin Excipient Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: China, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: India, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: India, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Japan, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Japan, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Australia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Australia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Indonesia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Indonesia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: South Korea, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: South Korea, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Western Europe, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Western Europe, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: UK, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: UK, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Germany, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Germany, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: France, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: France, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Italy, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Italy, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Spain, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Spain, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Eastern Europe, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Eastern Europe, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Russia, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Russia, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: North America, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: North America, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: USA, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: USA, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Canada, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Canada, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: South America, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: South America, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Brazil, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Brazil, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Middle East, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Middle East, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Africa, Albumin Excipient Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Africa, Albumin Excipient Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Albumin Therapeutics LLC Financial Performance
  • Figure 54: Biotest AG Financial Performance
  • Figure 55: CSL Behring Financial Performance
  • Figure 56: Grifols S.A. Financial Performance
  • Figure 57: HiMedia Laboratories LLC Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the Albumin Excipient market?

Albumin excipient is a type of protein that is found in blood. An excipient is an inactive ingredient that serves as a carrier or stabilizer for the active pharmaceutical ingredient. For further insights on the Albumin Excipient market, request a sample here

How will the Albumin Excipient market drivers and restraints affect the market dynamics? What forces will shape the Albumin Excipient industry going forward?

The Albumin Excipient market major growth driver - Chronic Disease Rise Fuels Albumin Excipient Market Growth. For further insights on the Albumin Excipient market, request a sample here

What is the forecast market size or the forecast market value of the Albumin Excipient market?

The Albumin Excipient market size has grown strongly in recent years. The albumin excipient market size has grown strongly in recent years. It will grow from$4.85 billion in 2024 to $5.2 billion in 2025 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to biopharmaceutical industry growth, increased adoption of biologics, risen prevalence of chronic diseases, clinical advancements and drug innovation, increased focus on drug delivery The albumin excipient market size is expected to see strong growth in the next few years. It will grow to $6.77 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to continued biopharmaceutical expansion, growing biologics pipeline, rising geriatric population, global vaccination initiatives, increasing drug development investments. Major trends in the forecast period include biodegradable and biocompatible properties, collaborations and partnerships in research, regulatory compliance and quality standards, application in cell therapy, customization and tailored solutions. For further insights on the Albumin Excipient market, request a sample here

How is the Albumin Excipient market segmented?

The albumin excipient market covered in this report is segmented –
1) By Product: Human Serum Albumin, Recombinant Albumin
2) By End-Users: Pharmaceutical And Biotechnology Industry, Research Institutes, Other End Users Subsegments:
1) By Human Serum Albumin: 5% Human Serum Albumin, 20% Human Serum Albumin
2) By Recombinant Albumin: Recombinant Human Serum Albumin, Recombinant Bovine Serum Albumin For further insights on the Albumin Excipient market,
request a sample here

Which region has the largest share of the Albumin Excipient market? What are the other regions covered in the report?

North America was the largest region in the Albumin Excipient market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global albumin excipient market report during the forecast period. The regions covered in the albumin excipient market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the Albumin Excipient market, request a sample here.

Who are the major players in the Albumin Excipient market?

Major companies operating in the albumin excipient market include Albumin Therapeutics LLC, Biotest AG, CSL Behring,Grifols S.A., HiMedia Laboratories LLC, InVitria Inc., Medxbio Pte Ltd., Octapharma AG, RayBiotech Inc., SeraCare Life Sciences Inc., Sigma-Aldrich Pty. Ltd., Hualan Biological Engineering Inc., Kedrion Biopharma, LFB USA Inc., Shanghai RAAS Blood Products Co. Ltd., Baxter International Inc., Merck KGaA, Thermo Fisher Scientific Inc., Albumedix A/S, Bio Products Laboratory Ltd., Shire Plc., Ventria Bioscience Inc., Novartis AG, China Biologic Products Holdings Inc., ProMetic Life Sciences Inc., Sanquin, Biopharma, Takeda Pharmaceutical Company Limited, FUJIFILM Irvine Scientific Inc. . For further insights on the Albumin Excipient market, request a sample here.

What are the key trends in the Albumin Excipient market?

Major trends in the Albumin Excipient market include Innovative Strategic Partnership Propel Market Growth. For further insights on the Albumin Excipient market, request a sample here.

What are the major opportunities in the Albumin Excipient market? What are the strategies for the Albumin Excipient market?

For detailed insights on the major opportunities and strategies in the Albumin Excipient market, request a sample here.

How does the Albumin Excipient market relate to the overall economy and other similar markets?

For detailed insights on Albumin Excipient's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Albumin Excipient industry?

For detailed insights on the mergers and acquisitions in the Albumin Excipient industry, request a sample here.

What are the key dynamics influencing the Albumin Excipient market growth? SWOT analysis of the Albumin Excipient market.

For detailed insights on the key dynamics influencing the Albumin Excipient market growth and SWOT analysis of the Albumin Excipient industry, request a sample here.